AAUM (Average Assets Under Management) of ₹1,063.05 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 74.2% | 73.3% | ▼ -1.0% |
| Healthcare Services | 21.8% | 21.6% | ▼ -0.2% |
| Insurance | 0.9% | 0.8% | ● -0.1% |
| Chemicals & Petrochemicals | 0.8% | 0.8% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 73.3% | 74.9% | ▲ +1.7% |
| Healthcare Services | 21.6% | 21.6% | ● +0.0% |
| Insurance | 0.8% | 0.7% | ● -0.1% |
| Chemicals & Petrochemicals | 0.8% | 0.7% | ● -0.1% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Dr. Lal Path Labs Limited ₹37.77 Cr |
Healthcare Services | 2.10% | 3.51% | +1.41% |
| 2 | Cipla Limited ₹68.71 Cr |
Pharmaceuticals & Biotechnology | 5.16% | 6.38% | +1.22% |
| 3 | Sai Life Sciences Limited ₹48.36 Cr |
Pharmaceuticals & Biotechnology | 4.20% | 4.49% | +0.29% |
| 4 | Biocon Limited ₹15.63 Cr |
Pharmaceuticals & Biotechnology | 1.19% | 1.45% | +0.26% |
| 5 | Abbott India Limited ₹35.08 Cr |
Pharmaceuticals & Biotechnology | 3.03% | 3.26% | +0.23% |
| 6 | Emcure Pharmaceuticals Limited ₹34.54 Cr |
Pharmaceuticals & Biotechnology | 2.99% | 3.21% | +0.22% |
| 7 | Mankind Pharma Limited ₹38.95 Cr |
Pharmaceuticals & Biotechnology | 3.41% | 3.62% | +0.21% |
| 8 | Shilpa Medicare Ltd ₹15.39 Cr |
Pharmaceuticals & Biotechnology | 1.27% | 1.43% | +0.16% |
| 9 | Ajanta Pharma Limited ₹46.82 Cr |
Pharmaceuticals & Biotechnology | 4.22% | 4.35% | +0.13% |
| 10 | Jubilant Pharmova Limited ₹6.49 Cr |
Pharmaceuticals & Biotechnology | 0.50% | 0.60% | +0.10% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited ₹92.79 Cr |
Pharmaceuticals & Biotechnology | 9.19% | 8.61% | -0.58% |
| 2 | Apollo Hospitals Enterprise Limited ₹69.35 Cr |
Healthcare Services | 6.85% | 6.44% | -0.41% |
| 3 | Fortis Healthcare Limited ₹26.10 Cr |
Healthcare Services | 2.79% | 2.42% | -0.37% |
| 4 | Torrent Pharmaceuticals Limited ₹99.97 Cr |
Pharmaceuticals & Biotechnology | 9.57% | 9.28% | -0.29% |
| 5 | Jupiter Life Line Hospitals Limited ₹16.66 Cr |
Healthcare Services | 1.76% | 1.55% | -0.21% |
| 6 | Pfizer Limited ₹10.87 Cr |
Pharmaceuticals & Biotechnology | 1.19% | 1.01% | -0.18% |
| 7 | Thyrocare Technologies Limited ₹18.94 Cr |
Healthcare Services | 1.94% | 1.76% | -0.18% |
| 8 | Lupin Limited ₹31.71 Cr |
Pharmaceuticals & Biotechnology | 3.10% | 2.94% | -0.16% |
| 9 | Vinati Organics Limited ₹7.47 Cr |
Chemicals & Petrochemicals | 0.77% | 0.69% | -0.08% |
| 10 | GlaxoSmithKline Pharmaceuticals Limited ₹8.97 Cr |
Pharmaceuticals & Biotechnology | 0.90% | 0.83% | -0.07% |
39 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹99.97 Cr |
Pharmaceuticals & Biotechnology |
9.28%
|
|
| 2 |
₹92.79 Cr |
Pharmaceuticals & Biotechnology |
8.61%
|
|
| 3 |
₹69.35 Cr |
Healthcare Services |
6.44%
|
|
| 4 |
₹68.71 Cr |
Pharmaceuticals & Biotechnology |
6.38%
|
|
| 5 |
₹48.70 Cr |
Pharmaceuticals & Biotechnology |
4.52%
|
|
| 6 |
₹48.36 Cr |
Pharmaceuticals & Biotechnology |
4.49%
|
|
| 7 |
₹46.82 Cr |
Pharmaceuticals & Biotechnology |
4.35%
|
|
| 8 |
₹38.95 Cr |
Pharmaceuticals & Biotechnology |
3.62%
|
|
| 9 |
₹37.77 Cr |
Healthcare Services |
3.51%
|
|
| 10 |
₹35.08 Cr |
Pharmaceuticals & Biotechnology |
3.26%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.